Joaquín Serena Leal

Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data

C. Gerloff, D. Blacker, C. Anderson, 2020, The Lancet.

Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial

C. Gerloff, T. Neumann-Haefelin, M. Endres, 2020, Neurological Research and Practice.

Granulocyte Colony–Stimulating Factor in Patients With Acute Ischemic Stroke: Results of the AX200 for Ischemic Stroke Trial

Á. Chamorro, B. Norrving, M. Fisher, 2013, Stroke.

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study

S. Warach, M. Kaste, W. Hacke, 2009, The Lancet Neurology.

Workflow Times and Outcomes in Patients Triaged for a Suspected Severe Stroke

Juan B. Gómez, J. C. Molina, Jose Carlos Molina, 2022, Annals of neurology.

C-Reactive Protein as a Prognostic Marker After Lacunar Stroke: Levels of Inflammatory Markers in the Treatment of Stroke Study

Mark D. Johnson, David C. Anderson, P. Karanjia, 2014, Stroke.

Granulocyte Colony–Stimulating Factor in Patients With Acute Ischemic Stroke: Results of the AX200 for Ischemic Stroke Trial

E. Ringelstein, Á. Chamorro, B. Norrving, 2013, Stroke.